Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 717 of 1,261

  1. US 9217024

    ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

    Acumen Pharmaceuticals, Inc. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  2. US 9217007

    Platinum anticancer agents

    The Regents of the University of California · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  3. US 9216178

    Dry blend formulation of tetrahydrobiopterin

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  4. US 9216971

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  5. US 9217148

    Exon skipping compositions for treating muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  6. US 9217040

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  7. US 9217026

    Method of inactivating a glucocorticoid receptor gene in an isolated cell

    Sangamo Biosciences, Inc. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  8. US 9217010

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  9. US 9216983

    Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  10. US 9216969

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  11. US 9216993

    Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  12. US 9216213

    Adjuvanted rabies vaccine with improved viscosity profile

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  13. US 9216240

    Differential loading of drug-eluting medical devices

    Covidien LP · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  14. US 9216220

    Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  15. US 9216198

    Compositions and medical devices for controlled release of nitric oxide and methods of production thereof

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  16. US 9216214

    Replication-competent adenoviral vectors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  17. US 9216155

    Synthetic nanostructures including nucleic acids and/or other entities

    Northwestern University · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  18. US 2015359783

    PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF

    BIAL PORTELA & Cª S A [PT] · Granted Dec 17, 2015 · Expires Dec 12, 2035

    granted

  19. CA 2951771

    COMPOSITIONS ET METHODES PERMETTANT DE PREVENIR LES INFECTIONS

    BIOCODEX [FR] · Granted Dec 17, 2015 · Expires Dec 12, 2035

    granted

  20. US 9212191

    6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitor

    GILEAD CONNECTICUT, INC. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  21. US 9212273

    Elastomer formulations

    MOLECULAR REBAR DESIGN, LLC · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  22. US 9211323

    Compositions and methods for administration of vaccines against dengue virus

    Takeda Vaccines, Inc. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  23. US 9211328

    Modulation of NKG2D for prolonging survival of a hematopoietic graft

    The Regents of the University of California · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  24. US 9212149

    Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.